Triclinic Labs Adds New Laboratory Space and Chemical Development Capabilities

WEST LAFAYETTE, Ind., May 31, 2011 /PRNewswire/ — Today Triclinic Labs
announced it has opened an additional 5000 square feet of laboratory and office
space in the renovated Innovatech Building in West Lafayette, IN. The new
facilities house state-of-the-art instrumentation, organic and analytical
chemistry laboratories, office space for newly created scientific positions,
conference rooms, and employee common areas. With this latest expansion
Triclinic is adding bulk powder characterization and interaction services,
dissolution testing, high-throughput solid-form screening and selection, new
thermal and spectroscopic chemical analysis techniques, a state-of-the-art
Rigaku SmartLab X-Ray Powder Diffractometer, CILAS 1180 Laser Particle Size
analyzer, and other physicochemical analysis capabilities to its extensive list
of services. The new lab will allow the addition of ten positions in the next 24
months.

“We’re excited to be able to add additional scientific capabilities and capacity
to our extensive physical and analytical chemistry service offerings. Our goal
is to provide more unique services for our clients with our current expansion,”
said Shawn C. Comella, Triclinic’s CEO. “The demand from our clients for
materials characterization and solid-form screening and development has been
overwhelming. We are pleased to be able to provide the additional techniques and
expertise our pharmaceutical and intellectual property clients have requested of
us. Despite a recovering economy, we continue to add jobs at a regular interval
and reinvest in our small and large molecule research and development
offerings,” he added.

This is the third expansion for Triclinic Labs since its inception in April of
2009.

For more information please contact:
Triclinic Labs, Inc.

http://www.tricliniclabs.com

765-588-6200

About Triclinic Labs:

Triclinic Labs was founded by David E. Bugay, G. Patrick Stahly, Shawn C.
Comella, and Scott L. Childs.

Our goal is to provide the most advanced consulting and laboratory capabilities
for solid-state chemical development. We routinely help the pharmaceutical and
specialty chemicals industries but have also analyzed and studied counterfeit
items, minerals, semiconductors, and other unique molecules. Over the last 15
years we’ve helped the world’s chemical development groups understand, discover,
improve, and protect solid-state materials.

To date we’ve

— Collaborated on over 1000 drug substances, drug products, and fine
chemicals
— Conducted more than 500polymorph, salt, and cocrystal projects
— Acted as consultants for 90% of the top 50 pharmaceutical companies
worldwide
— Acted as witnesses and experts for nearly 100chemical intellectual
property& legal matters worldwide

Our experts have contributed to more development milestones and legal matters
than any other group of contract physical and analytical chemistry experts. The
principals at Triclinic were the scientific and operations drivers behind the
growth of SSCI, a solid-state contract laboratory, which was the industry leader
for more than a decade. The principals’ shared belief in the value of customer
focus, scientific integrity, and extensive experience led to the decision to
create new capabilities at Triclinic Labs.

SOURCE Triclinic Labs